Literature DB >> 3151920

New 14-aminomorphinones and codeinones.

J Lewis1, C Smith, P McCarthy, D Walter, R Kobylecki, M Myers, A Haynes, C Lewis, K Waltham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3151920

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN： 1046-9516


× No keyword cloud information.
  7 in total

1.  14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.

Authors:  Guo Li; Lindsey C K Aschenbach; Hengjun He; Dana E Selley; Yan Zhang
Journal:  Bioorg Med Chem Lett       Date:  2008-12-29       Impact factor: 2.823

2.  Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.

Authors:  Yunyun Yuan; Guo Li; Hengjun He; David L Stevens; Patrick Kozak; Krista L Scoggins; Pallabi Mitra; Phillip M Gerk; Dana E Selley; William L Dewey; Yan Zhang
Journal:  ACS Chem Neurosci       Date:  2011-05-06       Impact factor: 4.418

Review 3.  Most recent developments and modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan derivatives.

Authors:  L Stavitskaya; A Coop
Journal:  Mini Rev Med Chem       Date:  2011-10       Impact factor: 3.862

4.  Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effects of changes to the chain linking of the C14-amino group to the aryl ring.

Authors:  David Rennison; Humphrey Moynihan; John R Traynor; John W Lewis; Stephen M Husbands
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

5.  Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.

Authors:  Yan Zhang; Orgil Elbegdorj; Yunyun Yuan; Irina O Beletskaya; Dana E Selley
Journal:  Bioorg Med Chem Lett       Date:  2013-05-16       Impact factor: 2.823

6.  Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.

Authors:  Guo Li; Lindsey C Aschenbach; Jianyang Chen; Michael P Cassidy; David L Stevens; Bichoy H Gabra; Dana E Selley; William L Dewey; Richard B Westkaemper; Yan Zhang
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

7.  Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats.

Authors:  Victor M Jimenez; Gabriel Castaneda; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2021-01-11       Impact factor: 4.030
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.